Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study

Bardia, Aditya, Krop, Ian E., Kogawa, Takahiro · Journal of Clinical Oncology · 2024